Drugs / MVA-CN54
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03408262 | Oct 2017 → Feb 2020 | HIV infectious disease | Imperial College London | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA-CN54 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03408262 ↗ |
| Route | Intramuscular | “I.M. MVA-CN54” NCT03408262 ↗ |